BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ozkizilcik A, Sharma A, Lafuente JV, Muresanu DF, Castellani RJ, Nozari A, Tian ZR, Mössler H, Sharma HS. Nanodelivery of cerebrolysin reduces pathophysiology of Parkinson's disease. Nanoneuroprotection and Nanoneurotoxicology. Elsevier; 2019. pp. 201-46. [DOI: 10.1016/bs.pbr.2019.03.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Hu D, Cui Y, Zhang J. Nervonic Acid Ameliorates Motor Disorder in Mice with Parkinson’s Disease. Neurochem J 2021;15:317-24. [DOI: 10.1134/s1819712421030065] [Reference Citation Analysis]
2 Hu D, Cui Y, Zhang J. Nervonic acid amends motor disorder in a mouse model of Parkinson's disease. Transl Neurosci 2021;12:237-46. [PMID: 34055392 DOI: 10.1515/tnsci-2020-0171] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
3 Rajib D. Central nervous system diseases associated with blood brain barrier breakdown - A Comprehensive update of existing literatures. J Neurosci Neurol Disord 2020;4:053-62. [DOI: 10.29328/journal.jnnd.1001035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]